Newland Pharmaceutical Co., Ltd. (SZSE: 301277)
Health Care · Pharmaceuticals · CN
CN¥10.76
+2.77% today · -17.7% 1Y
Newland Pharmaceutical Co., Ltd. (SZSE: 301277) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $629.84M.
Over the last twelve months the share price has lost 17.7%, trading between 8.45 and 13.84.
Tweenvest scores Newland Pharmaceutical Co., Ltd. across four factors: quality 80/100, value 29/100, growth 56/100, dividend 51/100. Its strongest factor is quality.
301277 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $629.84M
- Revenue (TTM)
- $104.60M
- P/E
- 40.47
- EPS
- 0.27
- Dividend yield
- 1.86%
- Beta (5Y)
- 0.18
- 52-week high
- CN¥13.84
- 52-week low
- CN¥8.45
- Avg volume (3M)
- —
- Shares outstanding
- 392.08M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Chimin Health Management Co., Ltd.SHSE: 603222 | $636.24M | CN¥8.30 | +2.85% |
| Zhejiang Wecome Pharmaceutical Company LimitedSZSE: 300878 | $634.11M | CN¥29.90 | -0.86% |
| Shandong Wohua Pharmaceutical Co., Ltd.SZSE: 002107 | $633.39M | CN¥7.35 | +3.67% |
| Jianmin Pharmaceutical Group Co.,Ltd.SHSE: 600976 | $630.03M | CN¥27.51 | +2.42% |
| TTY Biopharm Company LimitedTPEX: 4105 | $629.11M | NT$80.90 | +2.53% |
| Senores Pharmaceuticals LimitedNSEI: SENORES | $628.13M | Rs1,320.00 | -2.19% |
| Wuhan Hvsen Biotechnology Co.,Ltd.SZSE: 300871 | $625.65M | CN¥20.91 | -0.90% |
| Henan Taloph Pharmaceutical Stock Co.,LtdSHSE: 600222 | $625.37M | CN¥7.78 | -1.39% |
Figures last refreshed Oct 11, 2026.